UBC-led study offers lessons for other nations on deregulating mifepristone
UNIVERSITY OF BRITISH COLUMBIA, Research News
NEWS RELEASE 14-SEP-2020
Removing restrictions on how mifepristone--the medical abortion drug--can be prescribed and dispensed in Canada greatly improved access to abortion, especially in rural communities across the country.
That's one of
the key findings of new University of British Columbia-led research published
today in the Annals of Family Medicine.
'Reluctant to prescribe': Local clinic says women wait weeks to access abortion pill
The executive director of the SHORE Centres says many family doctors are still not prescribing the pill
Paula Duhatschek · CBC News
Posted: Jul 22, 2019
A local sexual health resource centre says it's experiencing so much demand for the abortion pill, Mifegymiso, that patients often must wait two to three weeks to get it.
Mifegymiso is the brand name for the combination of two pills that is used to terminate pregnancies—but only up to nine weeks along.
Abortion-pill obstacles: How doctors’ reluctance and long-distance travel stop many Canadians from getting Mifegymiso
Two years ago, Canada was one of the last developed countries to make available a drug hailed as a safe alternative to surgical abortion. But it’s still out of reach for many beyond the major cities, a Globe analysis has found
Carly Weeks Health Reporter
July 13, 2019
The Globe and Mail
Doctors across Canada are refusing to write prescriptions for the abortion pill, forcing many women to travel to out-of-town clinics to get a prescription, according to a Globe and Mail analysis that reveals provincial access barriers and widespread reluctance on the part of medical professionals to provide abortion care.